P5 medicine: a plus for a personalized approach to oncology.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

34 citing papers in PubMed.

1. Applying the 5P framework to improve cancer prevention in European health systems.Journal of public health policy · 2026
   Article
2. Glioblastoma: Overview of Proteomic Investigations and Biobank Approaches for the Development of a Multidisciplinary Translational Network.Cancers · 2025
   Review
3. Patients' and clinicians' knowledge in cancer-related cognitive impairment and its implications: current perspective.Future oncology (London, England) · 2024
   Review
4. Toward Clinical Generative AI: Conceptual Framework.JMIR AI · 2024
   Article
5. Revolutionizing Sleep Health: The Emergence and Impact of Personalized Sleep Medicine.Journal of personalized medicine · 2024
   Review
6. Onco-Breastomics: An Eco-Evo-Devo Holistic Approach.International journal of molecular sciences · 2024
   Review
7. The Application of tDCS to Treat Pain and Psychocognitive Symptoms in Cancer Patients: A Scoping Review.Neural plasticity · 2024
   Article
8. Hopamine as Personalized Medicine for Persons with Parkinson's Disease.Journal of Parkinson's disease · 2023
   Article
9. Ethical issues in oncology practice: a qualitative study of stakeholders' experiences and expectations.BMC medical ethics · 2022
   Article
10. Medi-Cinema: A Pilot Study on Cinematherapy and Cancer as A New Psychological Approach on 30 Gynecological Oncological Patients.Cancers · 2022
    Article
11. From P4 medicine to P5 medicine: transitional times for a more human-centric approach to AI-based tools for hospitals of tomorrow.Open research Europe · 2022
    Article
12. Personalized, Predictive, Participatory, Precision, and Preventive (P5) Medicine in Rotator Cuff Tears.Journal of personalized medicine · 2021
    Article
13. Opportunities and Challenges of Web-Based and Remotely Administered Surveys for Patient Preference Studies in a Vulnerable Population.Patient preference and adherence · 2021
    Article
14. Patient Preferences for Lung Cancer Treatments: A Study Protocol for a Preference Survey Using Discrete Choice Experiment and Swing Weighting.Frontiers in medicine · 2021
    Article
15. Hereditary Gastric and Breast Cancer Syndromes Related to CDH1 Germline Mutation: A Multidisciplinary Clinical Review.Cancers · 2020
    Review
16. The clinical-care focused psychological interview (CLiC): a structured tool for the assessment of cancer patients' needs.Ecancermedicalscience · 2020
    Article
17. Image-Guided Thermal Ablation as an Alternative to Surgery for Papillary Thyroid Microcarcinoma: Preliminary Results of an Italian Experience.Frontiers in endocrinology · 2020
    Article
18. A P5 Approach to m-Health: Design Suggestions for Advanced Mobile Health Technology.Frontiers in psychology · 2018
    Article
19. Memories of paternal relations are associated with coping and defense mechanisms in breast cancer patients: an observational study.BMC psychology · 2017
    Observational
20. How Do Patients Experience Individualized Medicine? A Qualitative Interview-based Study of Gene Expression Analyses in the Treatment of Breast Cancer.Geburtshilfe und Frauenheilkunde · 2017
    Article

Corrections and comments

• Comment on
  Predictive, personalized, preventive, participatory (P4) cancer medicine.2011

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as